4//SEC Filing
Sullivan Christopher Ryan 4
Accession 0001628280-23-021962
CIK 0001534120other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:41 PM ET
Size
4.7 KB
Accession
0001628280-23-021962
Insider Transaction Report
Form 4
Sullivan Christopher Ryan
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-06-09$3.42/sh+511$1,748→ 1,262 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001810417
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:41 PM ET
- Size
- 4.7 KB